• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤微环境响应型 BSA 纳米载体用于联合化疗/化学动力学癌症治疗。

Tumor microenvironment-responsive BSA nanocarriers for combined chemo/chemodynamic cancer therapy.

机构信息

School of Biological and Food Engineering, Anhui Polytechnic University, Wuhu, 241000, Anhui, China.

State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection & School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou, 215123, Jiangsu, China.

出版信息

J Nanobiotechnology. 2022 May 12;20(1):223. doi: 10.1186/s12951-022-01442-5.

DOI:10.1186/s12951-022-01442-5
PMID:35549949
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9097166/
Abstract

Tumor microenvironment (TME), characterized by high glutathione (GSH), high hydrogen peroxide (HO) and acidic pH levels, is favorable for the growth, invasion and metastasis of cancer cells. Taking advantage of the specific characteristics of tumors, TME-responsive GCBD NPs are designed to deliver nanoscale coordination polymers (NCPs, GA-Cu) and chemotherapy drugs (doxorubicin, DOX) based on bovine serum albumin (BSA) nanocarriers into cancer cells for combined chemodynamic therapy (CDT) and chemotherapy. In an acidic environment, GCBD NPs could release approximately 90% copper ions, which can not only consume overexpressed GSH to modulate the TME but can also react with endogenous HO in a Fenton-like reaction to achieve the CDT effect. Meanwhile, the released DOX could enter the nucleus of tumor cells and affect their proliferation to achieve efficient chemotherapy. Both in vitro and in vivo experiments showed that GCBD NPs had good biosafety and could effectively inhibit the growth of cancer cells. GCBD NPs are promising as a biocompatible nanoplatform to exploit TME characteristics for combined chemo and chemodynamic therapy, providing a novel strategy to eradicate tumors with high efficiency and specificity.

摘要

肿瘤微环境(TME)的特点是高谷胱甘肽(GSH)、高过氧化氢(HO)和酸性 pH 值,有利于癌细胞的生长、侵袭和转移。利用肿瘤的特异性特征,TME 响应性 GCBD NPs 被设计为基于牛血清白蛋白(BSA)纳米载体将纳米级配位聚合物(NCPs,GA-Cu)和化疗药物(阿霉素,DOX)递送至癌细胞中,用于联合化学动力学治疗(CDT)和化疗。在酸性环境中,GCBD NPs 可以释放约 90%的铜离子,不仅可以消耗过表达的 GSH 来调节 TME,还可以在类 Fenton 反应中与内源性 HO 反应,实现 CDT 效应。同时,释放的 DOX 可以进入肿瘤细胞的核内,影响其增殖,从而实现有效的化疗。体外和体内实验均表明,GCBD NPs 具有良好的生物安全性,并能有效抑制癌细胞的生长。GCBD NPs 有望成为一种具有生物相容性的纳米平台,利用 TME 特性进行联合化疗和化学动力学治疗,为高效、特异性地消灭肿瘤提供了一种新策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b8/9097166/451991fdca46/12951_2022_1442_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b8/9097166/590051114c4a/12951_2022_1442_Sch1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b8/9097166/abdb5a1b66f1/12951_2022_1442_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b8/9097166/6f3beedeb56e/12951_2022_1442_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b8/9097166/e4bea49a58bb/12951_2022_1442_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b8/9097166/568c2c293dcd/12951_2022_1442_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b8/9097166/ac1a4eb9200c/12951_2022_1442_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b8/9097166/451991fdca46/12951_2022_1442_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b8/9097166/590051114c4a/12951_2022_1442_Sch1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b8/9097166/abdb5a1b66f1/12951_2022_1442_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b8/9097166/6f3beedeb56e/12951_2022_1442_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b8/9097166/e4bea49a58bb/12951_2022_1442_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b8/9097166/568c2c293dcd/12951_2022_1442_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b8/9097166/ac1a4eb9200c/12951_2022_1442_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b8/9097166/451991fdca46/12951_2022_1442_Fig6_HTML.jpg

相似文献

1
Tumor microenvironment-responsive BSA nanocarriers for combined chemo/chemodynamic cancer therapy.肿瘤微环境响应型 BSA 纳米载体用于联合化疗/化学动力学癌症治疗。
J Nanobiotechnology. 2022 May 12;20(1):223. doi: 10.1186/s12951-022-01442-5.
2
A multivalent polyphenol-metal-nanoplatform for cascade amplified chemo-chemodynamic therapy.一种多价多酚-金属纳米平台,用于级联放大化学-化学动力学治疗。
Acta Biomater. 2024 Jan 1;173:389-402. doi: 10.1016/j.actbio.2023.11.006. Epub 2023 Nov 14.
3
Surface curvature-induced oriented assembly of sushi-like Janus therapeutic nanoplatform for combined chemodynamic therapy.表面曲率诱导的寿司状 Janus 治疗性纳平台的定向组装用于联合化学动力学治疗。
J Nanobiotechnology. 2023 Nov 15;21(1):425. doi: 10.1186/s12951-023-02138-0.
4
pH-Activatable copper-axitinib coordinated multifunctional nanoparticles for synergistic chemo-chemodynamic therapy against aggressive cancers.pH 激活型铜-阿昔替尼配位多功能纳米颗粒协同化学化学动力学疗法治疗侵袭性癌症。
Biomater Sci. 2023 Sep 12;11(18):6267-6279. doi: 10.1039/d3bm00861d.
5
Biodegradable copper-metformin nanoscale coordination polymers for enhanced chemo/chemodynamic synergistic therapy by reducing oxygen consumption to promote HO accumulation.可生物降解的铜-二甲双胍纳米级配位聚合物,通过降低耗氧量促进 HO 积累,增强化疗/化学动力学协同治疗。
J Mater Chem B. 2021 Mar 4;9(8):1988-2000. doi: 10.1039/d0tb02476g.
6
Bovine serum albumin-templated nanoplatform for magnetic resonance imaging-guided chemodynamic therapy.牛血清白蛋白模板纳米平台用于磁共振成像引导的化学动力学治疗。
J Nanobiotechnology. 2019 May 20;17(1):68. doi: 10.1186/s12951-019-0501-3.
7
A tumor microenvironment-responsive poly(amidoamine) dendrimer nanoplatform for hypoxia-responsive chemo/chemodynamic therapy.一种肿瘤微环境响应性聚酰胺-胺树枝状纳米平台,用于缺氧响应性化学/化学动力学治疗。
J Nanobiotechnology. 2022 Jan 21;20(1):43. doi: 10.1186/s12951-022-01247-6.
8
HO Self-Supplying and GSH-Depleting Nanocatalyst for Copper Metabolism-Based Synergistic Chemodynamic Therapy and Chemotherapy.用于基于铜代谢的协同化学动力疗法和化疗的自供氢和谷胱甘肽消耗纳米催化剂
Mol Pharm. 2023 Mar 6;20(3):1717-1728. doi: 10.1021/acs.molpharmaceut.2c00937. Epub 2023 Feb 21.
9
Glutathione/pH-responsive copper-based nanoplatform for amplified chemodynamic therapy through synergistic cycling regeneration of reactive oxygen species and dual glutathione depletion.用于通过活性氧协同循环再生和双重谷胱甘肽消耗实现增强化学动力疗法的谷胱甘肽/pH响应型铜基纳米平台
J Colloid Interface Sci. 2023 Dec 15;652(Pt A):329-340. doi: 10.1016/j.jcis.2023.08.043. Epub 2023 Aug 7.
10
Tumor microenvironment responsive theranostic agent for enhanced chemo/chemodynamic/photothermal therapy.肿瘤微环境响应型诊疗一体化试剂用于增强化疗/化学动力学/光热治疗。
Colloids Surf B Biointerfaces. 2022 Oct;218:112750. doi: 10.1016/j.colsurfb.2022.112750. Epub 2022 Aug 3.

引用本文的文献

1
Norcantharidin/Cu dual-depleting GSH nanocatalyst with pH-responsive for CT/CDT synergistic cancer therapy.具有pH响应性的去甲斑蝥素/铜双消耗谷胱甘肽纳米催化剂用于CT/CDT协同癌症治疗
Mater Today Bio. 2025 Jun 6;33:101959. doi: 10.1016/j.mtbio.2025.101959. eCollection 2025 Aug.
2
Innovative applications of silicon dioxide nanoparticles for targeted liver cancer treatment.二氧化硅纳米颗粒在靶向肝癌治疗中的创新应用。
Front Bioeng Biotechnol. 2025 May 12;13:1595772. doi: 10.3389/fbioe.2025.1595772. eCollection 2025.
3
Metal coordination polymer nanoparticles for cancer therapy.

本文引用的文献

1
Biomaterial-mediated internal radioisotope therapy.生物材料介导的内放射性同位素治疗。
Mater Horiz. 2021 May 1;8(5):1348-1366. doi: 10.1039/d0mh01761b. Epub 2021 Jan 12.
2
One-Pot Synthesis of Multifunctional Carbon-Based Nanoparticle-Supported Dispersed Cu Disrupts Redox Homeostasis to Enhance CDT.一锅法合成多功能碳基纳米颗粒负载的分散铜破坏氧化还原稳态以增强化学动力学疗法
Angew Chem Int Ed Engl. 2022 Jan 21;61(4):e202114373. doi: 10.1002/anie.202114373. Epub 2021 Dec 15.
3
Biomimetic metal-organic nanoparticles prepared with a 3D-printed microfluidic device as a novel formulation for disulfiram-based therapy against breast cancer.
用于癌症治疗的金属配位聚合物纳米颗粒。
Essays Biochem. 2025 Apr 10;69(2):EBC20253012. doi: 10.1042/EBC20253012.
4
Emerging Nanotechnology in Preclinical Pancreatic Cancer Immunotherapy: Driving Towards Clinical Applications.新兴纳米技术在临床前胰腺癌免疫治疗中的应用:迈向临床应用。
Int J Nanomedicine. 2024 Jul 2;19:6619-6641. doi: 10.2147/IJN.S466459. eCollection 2024.
5
Nanoscale coordination polymer Fe-DMY downregulating Poldip2-Nox4-HO pathway and alleviating diabetic retinopathy.纳米级配位聚合物Fe-DMY下调Poldip2-Nox4-HO通路并减轻糖尿病性视网膜病变
J Pharm Anal. 2023 Nov;13(11):1326-1345. doi: 10.1016/j.jpha.2023.05.002. Epub 2023 May 12.
6
Functionalized nanoparticles crossing the brain-blood barrier to target glioma cells.功能化纳米颗粒穿越血脑屏障靶向胶质瘤细胞。
PeerJ. 2023 Jul 4;11:e15571. doi: 10.7717/peerj.15571. eCollection 2023.
7
Protein-Caged Nanoparticles: A Promising Nanomedicine Against Cancer.蛋白质包裹的纳米颗粒:一种有前景的抗癌纳米药物。
Chonnam Med J. 2023 Jan;59(1):1-12. doi: 10.4068/cmj.2023.59.1.1. Epub 2023 Jan 25.
8
Review targeted drug delivery systems for norcantharidin in cancer therapy.综述坎尼汀在癌症治疗中的靶向药物传递系统。
J Nanobiotechnology. 2022 Dec 3;20(1):509. doi: 10.1186/s12951-022-01703-3.
9
Nanoparticle-Based Therapeutic Strategies for Enhanced Pancreatic Ductal Adenocarcinoma Immunotherapy.基于纳米颗粒的增强型胰腺导管腺癌免疫治疗策略
Pharmaceutics. 2022 Sep 24;14(10):2033. doi: 10.3390/pharmaceutics14102033.
10
Cancer Stem Cells and the Tumor Microenvironment: Targeting the Critical Crosstalk through Nanocarrier Systems.癌症干细胞与肿瘤微环境:通过纳米载体系统靶向关键串扰。
Stem Cell Rev Rep. 2022 Oct;18(7):2209-2233. doi: 10.1007/s12015-022-10426-9. Epub 2022 Jul 25.
用3D打印微流控装置制备的仿生金属有机纳米颗粒作为基于双硫仑的乳腺癌治疗新制剂。
Appl Mater Today. 2020 Mar;18. doi: 10.1016/j.apmt.2019.100492. Epub 2019 Nov 7.
4
A cascaded copper-based nanocatalyst by modulating glutathione and cyclooxygenase-2 for hepatocellular carcinoma therapy.通过调节谷胱甘肽和环氧化酶-2的级联铜基纳米催化剂治疗肝细胞癌。
J Colloid Interface Sci. 2022 Feb;607(Pt 2):1516-1526. doi: 10.1016/j.jcis.2021.09.049. Epub 2021 Sep 11.
5
Gallic acid for cancer therapy: Molecular mechanisms and boosting efficacy by nanoscopical delivery.没食子酸在癌症治疗中的应用:分子机制与纳米递药系统增强疗效。
Food Chem Toxicol. 2021 Nov;157:112576. doi: 10.1016/j.fct.2021.112576. Epub 2021 Sep 25.
6
The Sustainability of Energy Conversion Inhibition for Tumor Ferroptosis Therapy and Chemotherapy.能量转换抑制在肿瘤铁死亡治疗和化疗中的可持续性。
Small. 2021 Sep;17(38):e2102695. doi: 10.1002/smll.202102695. Epub 2021 Aug 4.
7
Chemodynamic nanomaterials for cancer theranostics.用于癌症治疗和诊断的化学动力学纳米材料。
J Nanobiotechnology. 2021 Jun 28;19(1):192. doi: 10.1186/s12951-021-00936-y.
8
Synergistic Cancer Photochemotherapy via Layered Double Hydroxide-Based Trimodal Nanomedicine at Very Low Therapeutic Doses.基于层状双氢氧化物的三模态纳米医学以极低治疗剂量协同癌症光化疗。
ACS Appl Mater Interfaces. 2021 Feb 17;13(6):7115-7126. doi: 10.1021/acsami.0c23143. Epub 2021 Feb 5.
9
Hydroxyapatite-Bovine Serum Albumin-Paclitaxel Nanoparticles for Locoregional Treatment of Osteosarcoma.用于骨肉瘤局部治疗的羟基磷灰石-牛血清白蛋白-紫杉醇纳米颗粒
Adv Healthc Mater. 2021 Jan;10(2):e2000573. doi: 10.1002/adhm.202000573. Epub 2020 Nov 9.
10
Tumor Microenvironment Stimuli-Responsive Fluorescence Imaging and Synergistic Cancer Therapy by Carbon-Dot-Cu Nanoassemblies.碳点-铜纳米组装体的肿瘤微环境刺激响应荧光成像及协同癌症治疗
Angew Chem Int Ed Engl. 2020 Nov 16;59(47):21041-21048. doi: 10.1002/anie.202007786. Epub 2020 Sep 11.